Parmax Pharma Ltd - 540359 - Board Meeting Outcome for Outcome Of Board Meeting And Results For Quarter Ended 30Th June, 2021.
Outcome of Board Meeting and Results for Quarter ended 30th June, 2021.14-08-2021
14-08-2021
Parmax Pharma Ltd - 540359 - Board Meeting Intimation for Intimation Of Board Meeting In Compliance With Reg. 29 Read With Reg. 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2021 ,inter alia, to consider and approve Intimation of Board Meeting in compliance with Reg. 29 read with Reg. 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.07-08-2021
Parmax Pharma Ltd - 540359 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30th June, 202119-07-2021
Parmax Pharma Ltd - 540359 - Shareholding for the Period Ended June 30, 2021
Parmax Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here19-07-2021
Parmax Pharma Ltd - 540359 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- YASH VORADesignation :- Company Secretary and Compliance Officer08-07-2021
Parmax Pharma Ltd - 540359 - Closure of Trading Window
This is to inform you that pursuant to Company''s Code of Practices and Procedures and Code of Conduct to Regulate, Monitor and Report Trading in Securities and SEBI (Prohibition of Insider Trading) Regulations, 2015, 'Trading Window' for dealing in securities of the Company for designated persons will remain closed with immediate effect till 48 hours after the declaration of financial results for the Quarter ended on 30th June, 2021. The date of announcement of the financial results for the Quarter ended on 30th June, 2021 shall be announced in due course.30-06-2021
Parmax Pharma Ltd - 540359 - Outcome Of Board Meeting And Results For Quarter And Financial Year Ended 31St March, 2021.
Outcome of Board Meeting and Results for Quarter and Financial year ended 31st March, 2021.29-06-2021
Parmax Pharma Ltd - 540359 - Outcome Of Board Meeting And Results For Quarter And Financial Year Ended 31St March, 2021.
Outcome of Board Meeting and Results for Quarter and Financial year ended 31st March, 2021.29-06-2021
Parmax Pharma Ltd - 540359 - Outcome Of Board Meeting And Results For Quarter And Financial Year Ended 31St March, 2021.
Outcome of Board Meeting and Results for Quarter and Financial year ended 31st March, 2021.29-06-2021